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Effects of dietary fish oil on renal insufficiency in rats with subtotal
nephrectomy. We studied the effects of fish oil on the progression of
renal insufficiency in rats with subtotal nephrectomy. Five weeks after
a 1-2/3 nephrectomy, sixteen rats were fed two different diets which
differed only in fat composition. Lipid in the control diet was primarily
beef tallow; that of the experimental diet, menhaden oil. Fish oil—fed
rats had significant increases in plasma creatinines, decreases in urinary
PGE2 and accelerated death rates. An additional twelve rats underwent
1-1/3 nephrectomies, and the same dietary manipulations, followed by
renal clearance, histologic and biochemical studies after 12 weeks on
the diets. Fish oil—fed rats again did worse, with decreased glomerular
filtration rates and filtration fractions, more proteinuria and more
glomerular sclerosis. Glomeruli and slices of cortex, medulla and
papillae from rats fed fish oil produced much less PGE2 and TXB2 than
dietary controls. Fish oil—induced suppression of renal POE2 may be
deleterious in this model and may outweigh the beneficial effect derived
from TXA2 suppression. In contrast to fish oil's potentially therapeutic
role in cardiovascular and immune—mediated renal disease, this diet is
detrimental in rat renoprival nephropathy. This illustrates the impor-
tance of examining the effects of fatty acid manipulation individually for
each disease entity.
Prostaglandins, specifically POE2 and P012, help maintain
renal blood flow and glomerular filtration in clinical conditions
associated with renal compromise, and thus are thought to be
beneficial [1—3], Conversely, thromboxane A2 (TXA2), another
cyclooxygenase metabolite, may contribute to the evolution of
certain renal diseases [2, 3].
Eicosanoids must be derived from polyunsaturated fatty
acids ingested in the diet. These fatty acids cannot be synthe-
sized de novo by mammals [4]. Arachidonic acid (AA), the
conventional precursor, contains four double bonds with its
terminal double bond at the "omega minus 6" position. Eicos-
apentaenoic acid (EPA), found in fish, contains five double
bonds with its terminal double bond at the "omega minus 3"
position [4]. AA is readily converted to the "2" or diene series
of cyclooxygenase metabolites; EPA may be converted to the
"3" or triene series [5—8]. TXA2 is a potent vasoconstrictive [4],
platelet aggregatory and leukocyte chemoadhesive agent [9],
EPA-derived TXA3 is biologically inert [5]. PG!3 however, has
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been reported to be equipotent to PGI2 [5]. It has also been
shown that EPA is converted to leukotriene B5 (LTB5) [10, 11]
which is much less biologically active than AA-derived LTB4
[10].
Greenland Eskimos, whose diets are rich in EPA, have
abnormal platelet function, prolonged bleeding times, and less
cardiovascular disease [12—14]. These changes correlate well
with the reduction in biologically active TXA2 [5]. Conclusions
gained from these population and in vitro analyses have served
as the rationale for the use of fish oil in the prevention of
cardiovascular disease [14, 15], with less attention to other
organ systems, specifically the kidney. Several studies have
shown that a fish oil—enriched diet prevents proteinuria in two
different models of genetic systemic lupus erythematosus [16,
17]. Another study, performed in humans, demonstrates that
fish oil supplements preserve renal function in IgA nephropathy
[18].
The objectives of our study were a) to determine the effects of
a fish oil-enriched diet on the course of the nonimmune—medi-
ated renal disease produced by surgical renal ablation and b) to
assess the effect of this dietary manipulation on renal POE2 and
TXB2 accumulation. We thought that the fish oil—enriched diets
might halt the progression of this renal disease, but contrary to
our expectations, in two separate experiments fish oil was
detrimental, resulting in the acceleration of both functional and
histological renal deterioration. We conclude that such a dietary
manipulation should not be used indiscriminantly, but rather
should be directed to specific diseases.
Methods
Surgery
Subtotal nephrectomies were performed on adult, female
Sprague—Dawley rats (Camm, Wayne, New Jersey, USA).
Through an abdominal incision, the right kidney was removed.
The left kidney was then exposed. For animals in Group I (16
rats) both the upper and lower poles were ligated tightly,
resulting in a 1-2/3 nephrectomy. For the twelve rats in Group
II, the right kidney was removed and only one pole of the left
kidney was ligated, resulting in a 1-1/3 nephrectomy. In order to
simulate a true clinical situation in which therapy is not initiated
until the disease is established, a five week interval was allowed
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Table 1. Fatty acid analysis of dietary lipids
Safflower oil
To provide
Menhaden oil Beef tallow essential
Fatty acid EPA-enriched diet Control diet fatty acids
14:0 8.2 2.7 0.11
16:0 13.5 23.9 6.38
16:1 13.5 5.3 0.57
18:0 5.5 17.7 2.45
18:1 12.5 41.2 11.9
18:2 5.2 6.1 73.3
20:3 (DHG) 1.4 <0.05 —
20:4(AA) 1.5 <0.05 —
20:5 (EPA) 14.4 <0.05 <0.05
18:3, 22:5, 22:6 14.0 — —
Numbers represent percent of the total fatty acid content.
between the renal ablative procedure and initiation of the
experimental diets.
The first experiment (Group I) was a pilot study, the goal of
which was to see if fish oil—enriched diets had any effect on the
course of renoprival nephropathy. Because significant differ-
ences in plasma creatinines between fish oil—fed and control
diet—fed rats were noted after 10 to 12 weeks (Results), in the
second set of experiments (Group II), formal renal clearance
measurements, renal segmental eicosanoid production and his-
tologic analysis were performed at this time point. In order to
perform these studies before the Group II rats were clinically
uremic, the less extensive ablative procedure was performed.
Diets (Table 1)
During the five-week interval between surgery and initiation
of experimental diets, rats were fed standard chow (Ralston
Purina, St. Louis, Missouri, USA). They were then divided into
two dietary subgroups with similar plasma creatinines and
pair—fed diets which differed only in the composition of fat.
Throughout the dietary study rats were housed individually in
metabolic cages.
The basic diet consisted of a fat—free power (TD 84010)
prepared by Teklad Test Diets, Madison Wisconsin, USA. To
this was added the dietary fat, either in the form of melted beef
tallow (ICN Nutritional Biochemicals, Cleveland, Ohio, USA)
for the rats fed the control diet or, for the rats fed the fish
oil—enriched diet, whole menhaden oil, a rich source of EPA
and other omega-3 polyunsaturated fatty acids (Table 1). This
menhaden oil was highly refined and processed with more than
99,5% of its fatty acids in triglyceride form. All nutrients,
minerals, and vitamins were equal in each diet and in compli-
ance with recommended nutritional requirements [191. The
composition of both regular and experimental diets after the
addition of fats was: carbohydrate, 50% wt/wt; protein, 19%
wt/wt; fat, 21% wt/wt; cellulose 5%, wt/wt; minerals (Teklad,
AIN-76, 170915), 4% 2/2; and vitamins (Teklad, 40060), includ-
ing Vitamin E to prevent oxidation of the fatty acids while in the
chow, 1% wt/wt. Sufficient safflower oil was added to the diets
to provide equal amounts of linoleate and arachidonate. All oils
were stored in a refrigerated room under nitrogen.
Biologic measurements
Every two weeks tail pressures were recorded while animals
were under light ether anesthesia, and blood was collected for
plasma creatinine, hematocrit, and platelet count. Twenty—four
hour urine collections were made on these days for PGE2,
TXB2, creatinine, and protein determinations, at which time
animals were only allowed access to water. Plasma and urine
creatinine were determined by the Jaffe reaction, measuring
both true creatinine and non-creatinine chromagens. Radioim-
munoassays for urinary PGE2 and TXB2 were performed on
unextracted urine samples stored at —20°C [201. Urinary pro-
tein measurements were determined by sulfosalicylic acid.
Clearance studies
DTPA and hippuran studies were performed on rats in Group
II (those with the 1-1/3 nephrectomy) after 12 weeks on the diets
(17 weeks postoperatively). Under ether anesthesia, flexible
catheters were inserted into the femoral artery, vein, and
bladder. An intravenous infusion of 2 ml/hr normal saline (20 U
sodium heparin/ml) was maintained. After the rat awoke a
stabilization period of approximately one hour was allowed.
The following isotopes were then injected into the venous
catheter: Technetium 99mDiethylenetriamine pentaacetic acid,
17 ,aCi, (99mTc DTPA, MediPhysics, Emeryville, California,
USA) to measure glomerular filtration rate (GFR) [21] and
lodohippurate Sodium, 10 MCi, (Hippuran ''i Mallinkrodt,
Inc., St. Louis, Missouri, USA) to measure renal plasma flow
(RPF) [221. After injection of the tracers, blood samples were
collected in heparinized capillary tubes at 5, 10, 15, 20, 30, 40,
60, and 80 minutes. Radioactivity versus time was plotted
semilogarithmically and clearances calculated. This single in-
jection method has been shown to yield results which correlate
well with simultaneously—performed standard clearances of
cold inulin and PAH [23]. After completion of the clearance
study animals were sacrificed, blood obtained for lipid and
chemical determinations, and the remnant kidney removed for
analysis.
Preparation and incubation of renal tissue for PGE2 and
TXB2 measurement
All preparation of renal tissue was carried out in ice—cold
normal saline. Slices of 0.5 mm thickness were made using a
Stadie—Riggs microtome. Several slices from each kidney were
fixed for light microscopic analysis. The remaining slices were
either further separated into cortical, medullary, or papillary
segments, or used for preparing glomeruli. Glomeruli were
isolated by a sequential sieving technique, as reported [24, 251.
This technique does not isolate severely sclerosed glomeruli, as
they tend to be fibrotic, imbedded in the cortex and do not
freely pass through the sieve. The resulting preparation con-
sisted of >95% glomeruli, the majority unencapsulated. The
average time between sacrifice of the rat and division of the
kidney into all these segments was no more than 90 minutes.
For incubation studies, the following buffer was used: NaC1
135 mEq/liter, KCI 10 mEq/liter, sodium acetate 10 mEq/liter,
Tris pH 7.4 20 mEq/liter, glucose 5 mm/liter. Fatty acid—free
bovine serum albumin (1 mg/mI) (Sigma) and Ca (2 mM) were
also included. Individual renal slices or glomerular aliquots
(approximately 500 to 800 glomeruli/aliquot) were resuspended
702 Scharschmidt et a!
Fig. 1. Effects of fish oil—enriched vs. control diets on renal function
and survival of the group I (I-2l3-nephrectomized) rat. A. Points depict
mean SEM plasma creatinine over an eighteen week period. Paren-
theses indicate number of alive rats. B. Points depict survival of these
rats. Arrows perpendicular to the ascissa denote mean SEM survival.
Symbols are: (•) Fish oil-enriched diet; (0) control diets. (* = P < 0.05
EPA-enriched diet vs. control diet.)
in one ml of buffer. Immediately prior to the experiment, the
incubation medium was replaced with fresh medium. Experi-
ments were then performed in a water bath at 37° for 10 minutes
with buffer alone, or buffer plus 2 tIM of the divalent cation
ionophore A23 187 (Sigma). At the end of the incubation,
supernate was aspirated and saved at —20°C for later eicosanoid
measurement. Renal tissue was washed and resuspended in 1 N
NaOH for protein determinations [261.
Radioimmunoassay (RIA) for PGE2 and TXB2
RIAs were performed on unextracted supernates and urines.
Samples were diluted from 1:50 to 1:100 and assayed at two or
more dilutions. PGE2 antibody was from the Institut Pasteur,
Paris; TXB2 antibody was purchased from Seragen. Cross—
reactivities of these antibodies with other diene eicosanoids are
published elsewhere [251. In our laboratory cross—reactivity of
the PGE2 antibody with PGE3 is 8%. Radioactive ligands
(3H)PGE2 (specific activity 120 to 170 Ci/mmol and (3H)TXB2
(specific activity 180 Ci/mmol) were purchased from Amersham
Radiochemicals, Arlington Hts., Illinois, USA. Buffer without
renal tissue was incubated in parallel experiments and served as
a blank. This blank never exceeded 5% of the experimental
values.
Preparation of tissue for light microscopic analysis
Renal slices from each rat were fixed in 10% neutral formalin,
dehydrated in alcohol and imbedded in paraffin. Four m
sections were then stained with Hematoxylin—Eosin (H-E).
Masson—Trjchrome stain was used in the evaluation of fibrosis.
Measurement of glomerular diameter
H-E stained sections were observed with an oculo-
micrometer. Only those glomeruli that presented an apparent
cross section were examined. Two perpendicular diameters of
each glomerulus were measured in nanometers and their aver-
age was considered as the individual glomerular diameter. All
sections of each kidney were evaluated for glomerular sclerosis.
The extent of tubular dilatation and atrophy, interstitial fibrosis,
vascular thickening, and nephrocalcinosis, was expressed as
"absent" (0), "questionable" (1), "mild" (2), "moderate" (3),
500
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or "severe" (4). Two pathologists evaluated the tissue sepa-
rately. At least 50 glomeruli per rat were evaluated histologi-
cally. All these examinations were done in a blinded manner.
Measurement of plasma lipids
Cholesterol was measured by the Fermco enzymatic method
for free cholesterol and cholesterol esters (Fermco Biochemi-
cal, Elk Grove Village, Illinois, USA). Triglycerides were
measured enzymatically using the Worthington Diagnostic Re-
agent Set (Cooper Biomedical, Diagnostic Division, Malvern,
Pennsylvania, USA).
Statistics
All results are reported as mean SEM. Statistical analysis
used was the Student's t-test. Whether the analysis was paired
or unpaired is indicated in Results.
Results
Group I (rats with 1 2/3 NX)
General parameters. After 12 weeks on the experimental
diets (17 weeks post-NX) there were no differences in the blood
pressures (mean SEM) (control diet 129 6 mm Hg vs. fish
oil—enriched diet 133 18 mm Hg), weights (control diet 291
17 g vs. fish oil—enriched diet 286 5 g) or proteinuria (control
diet 78 13 mg/24 hr vs. fish oil—enriched diet 79 20 mg/24
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Fig. 2. Effect of control vs. fish oil—enriched diets on radioimmunoas-
sayable urinary TXB2 and PGE2 in group I (1-2l3NX) rats. Bars depict
mean SEM. Numbers within the bars represent number of rats.
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Table 2. Effects offish oil—enriched vs. control diet on the 1-1/3 nephrectomized rat (Group II)
Weeks on diet
0 2 4 7 10 12
5wkpNX 7wkpNX 9wkpNX l2wkpNX l5wkpNX l7wkpNX
BP mm Hg
Control diet 149 10 162 20 142 16 113 5 100 8 102 14
Fish oil diet 134 8
NS
153 10
NS
138 7
NS
118 6
NS
115 4
NS
125 12
NS
Weight g
Control diet 236 9 270 6 284 5 289 4 286 3 293 8
Fish oil diet 226 9
NS
269 5
NS
278 7
NS
280 7
NS
280 7
NS
294 8
NS
Hematocrit %
Control diet 45 1 40 2 42 3 47 1 46 1 47 I
Fish oil diet 45 2
NS
43 1
NS
43 2
NS
46 1
NS
45 1
NS
47 2
NS
Platelets x 1000
Control diet 814 184 998 202 642 197 588 164 619 165 588 132
Fish oil diet 1,201 282
NS
1,240 469
NS
602 158
NS
586 145
NS
549 134
NS
530 127
NS
Numbers represent mean 5EM; N = 6; NS = not significant
hr). Fish oil—fed rats had a gradual drop in hematocrit during the
dietary study which was significantly different from dietary
controls (P < 0.02) at week 14 of the diets (control diet 42 1%
vs. fish oil—enriched 34 3%). Because post-mortem examina-
tions revealed no evidence of infection or blood loss in the
fish—oil fed rats, we attributed the anemia to their elevated
creatinines. We did not perform statistical comparisons of
blood pressure, proteinuria, hematocrit or weight beyond four-
teen weeks after initiating the experimental diets because so
few rats eating the fish oil—enriched diet were alive.
Renal function. Figure lA depicts the progression of plasma
creatinine concentration versus time. Before initiation of diets,
mean plasma creatinine of the rats to be fed fish oil—enriched
diets as well as those to be fed the control diet (± sEM) was 1.3
0.1 mg%. Rats fed fish oil diets subsequently suffered a more
rapid rise in plasma creatinine. This became statistically signif-
icant by week 10 to 12 on the diet (15 to 17 weeks postopera-
tively).
Survival. After initiation of the experimental diets, the rats
fed control diets lived an additional 21 3 weeks (mean SEM,
Fig. IB). Those fed the fish oil—enriched diet survived a
significantly shorter time (P < 0.05), 14 2 weeks (mean
sEM). During the two weeks prior to death, all rats ate less and
lost weight.
Urinary PGE2 and TXB2. Before initiation of the diets, there
was no significant difference in 24 hour urinary PGE2 (rats to be
fed fish oil 61 15 ng vs. those to be fed control diet, 50 8 ng).
These values are markedly reduced from normal, non-nephrec-
tomized rats analyzed at the same time (360 90 ng, N = 3).
However, when urinary PGE2 is normalized to creatinine
clearance, renal PGE2 production by nephrectomized rats ex-
ceeded that of normal rats (150 14 g PGE2/cc/min vs. 83
27 g PGE2/cc/min). After 12 weeks on the diet, the urinary
PGE2 of the rats on the control chow had not changed, but the
urinary PGE2 of the rats fed fish oil was markedly reduced (Fig.
2). This reduction was significant whether compared to the rats
on the control diets at week 12 or to EPA-fed rats prior to the
initiation of diets.
Table 3. Radionuclide clearances (week 12), and protein excretion
(before diet and at week 12 of diet) of 1-1/3 nephrectomized rats
Control Fish oil
diet diet
N=5 N=6 P
131J hippuran clearance
Renal Plasma flow mI/mm/rat 2.91 0.55 3.87 0.50 NS
Tcssm DTPA clearance
glomerular filtration rate ml/ 1.09 0.15 0.72 0.12 <0.05
mm rat
Filtration fraction GFR/RPF 0.37 0.08 0.19 0.02 <0.05
Proteinuria mg/24 hr
beginning of diet 18 6 20 8 NS
Week 12 of diet 38 10 81 22 <0.05
Numbers represent mean 5EM; NS = not significant
Urinary TXB2 five weeks after subtotal nephrectomy was
similar in the rats to be fed control or fish oil—enriched diets (13
2 ng and 15 2 ng, respectively) which is significantly greater
than non-nephrectomized rats (6 2 ng). Rats fed the fish
oil—enriched diet subsequently had a significant reduction in
urinary TXB2 over the study period.
In summary, we found the following in the pilot study: (1)
plasma creatinines rose more quickly in 1-2/3 NX rats fed fish
oil—enriched diets than in those rats on the control diet; (2) fish
oil fed rats were more anemic. We attribute this to their more
severe renal insufficiency; (3) urinary PGE2 and TXB2 were
significantly reduced in fish oil—fed rats; and (4) fish oil—fed rats
did not live as long as their dietary controls.
Group II
General parameters. After 12 weeks on the diet (Table 2),
rats with less extensive renal ablation (1-1/3 NX) all had similar
weights (fish oil—fed rats, 294 8 g; control diet rats, 293 8 g),
hematocrits (fish oil—fed rats, 47 2% control diet rats 47
1%), and platelet counts (fish oil—fed rats, 530,000 126,700;
control diet rats 588,000 132,000). The hematocrits of all
Group II rats were higher than those in Group I. We attribute
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Fig. 1. Effects of fish oil—enriched vs. control diets on renal functionand survival of the group I (I-2l3-nephrectomized) rat. A. Points depictmean SEM plasma creatinine over an eighteen week period. Paren-theses indicate number of alive rats. B. Points depict survival of theserats. Arrows perpendicular to the ascissa denote mean SEM survival.Symbols are: (•) Fish oil-enriched diet; (0)n roldi t . (* =< 0.05EPA-enriched diet vs. control diet.)
in one ml of buffer. Immediately prior to the experiment, theincubation medium was replaced with fresh medium. Experi-
ments were then performed in a water bath at 37° for 10 minutes
with buffer alone, or buffer plus 2 tIM of the divalent cationionophore A23 187 (Sigma). At the end of the incubation,supernate was aspirated and saved at —20°Cfor lat r eicosanoid
measurement. Renal tissue was washed and resuspended in 1 NNaOH for protein determinations [261.
Radioimmunoassay (RIA) for PGE2 and TXB2RIAs were performed on unextracted supernates and urines.Samples were diluted from 1:50 to 1:100 and assayed at two or
more dilutions. PGE2 antibody was from the Institut Pasteur,Paris; TXB2 antibody was purchased from Seragen. Cross—reactivities of these antibodies with other diene eicosanoids arepublished elsewhere [251. In our laboratory cross—reactivity ofthe PGE2 antibody with PGE3 is 8%. Radioactive ligands(3H)PGE2 (specific activity 120 to 170 Ci/mmol and (3H)TXB2(specific activity 180 Ci/mmol) were purchased from AmershamRadiochemicals, Arlington Hts., Illinois, USA. Buffer withoutrenal tissue was incubated in parallel experiments and served asa blank. This blank never exceeded 5% of the experimentalv lu .
Preparation of tissue for light microscopic analysisRenal slices from each rat were fixed in 10% neutral formalin,dehydrated in alcohol and imbedded in paraffin. Four m
sections were then stained with Hematoxylin—Eosin (H-E).Masson—Trjchrome stain was used in the evaluation of fibrosis.Measurement of glomerular diameterH-E stained sections were observed with an oculo-
micrometer. Only those glomeruli that presented an apparentcross section were examined. Two perpendicular diameters of
each glomerulus were measured in nanometers and their aver-
age was considered as the individual glomerular diameter. All
sections of each kidney were evaluated for glomerular sclerosis.The extent of tubular dilatation and atrophy, interstitial fibrosis,
vascular thickening, and nephrocalcinosis, was expressed as
"absent" (0), "questionable" (1), "mild" (2), "moderate" (3),
5003J.8
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or "severe" (4). Two pathologists evaluated the tissue sepa-
rately. At least 50 glomeruli per rat we e evaluated histol gi-
cally. All these examinations were done in a blinded manner.
Measur ment of plasma lipids
Cholesterol was measured by the Fermco enzymatic method
for free cholesterol and chol sterol esters (Fermco Biochemi-
cal, Elk Grove Village, Illinois, USA). Triglycerides were
measured enzymatically using the Worthington Diagnostic Re-
agent Set (Cooper Biomedical, Diagnostic Division, Malvern,Pennsylvania, USA).Stat stics
All results are reported as mean SEM. Statistical analysis
used was the Student's t-test. Whether the analysis was paired
or unpaired is indicated in Results.Results
Group I (rats with 1 2/3 NX)General parameters. Aft r12 weeks on e experimental
diets (17 weeks post-NX) there we e no differences in the bloodpressures (meanSEM) (control di t 1296 m Hg vs. fi hoil—enrich d diet 13318 mm Hg), weights (control diet 29117 g vs. fish oil—enriched diet 2865 g) or proteinuria (controldiet 7813 mg/24 hr vs. fish oil— n ich d diet 7920 mg/24
Ba)CU!510 15 18Start fdifferent Weeks on di tLP< .05P<0.05P<0.051604205 10 1  20 25 30Stafdifferent Weeks on d e32P<0.02I10P<0.02-l
Norm lratL_______ __ _ __ __c ntr liBefor  dietsWeek l2of diets
12/3 NX RatsFig.2. Effect of control vs. fish oil—enriched diets on radioimmunoas-
sayable urinary TXB2 and PGE2 i  group I (1-2l3NX) rats. Bars depict
mean SEM. Numbers within the bars represent number of rats.
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Fig. 3. Histopathology qf remnant renal segments from fish oil—fed rats vs. dietary controls (Group 1!). Masson Trichrome Stain. A and B: Renal
tissue from normal age—matched unperfused kidney (A xIOO, B x250). All glomeruli appear normal and the interstitium is devoid of infiltrating
cells. C and D are from 1-1/3 nephrectomized rats fed normal diets. C shows interstitial fibrosis with tubular dilatation and atrophy (C, >< 100). D(x250) shows two glomeruli, one with glomerular adhesions and focal sclerosis. E and F are from 1-1/3 nephrectomized rats fed fish oil—enriched
diets. The interstitial disease is slightly more severe (E, >< 100), however, the major changes occur in the glomeruli, more of which are totally
sclerosed (F, x25(J).
this to a less extensive renal ablation and hence less severe experimental diets, mean plasma creatinine (± SEM) was 1.1
renal functional impairment than Group I. Blood pressures in
.1 mg% (Table 3). This value is less than that of the Group I
Group II, although slightly elevated, were lower than in Group rats. At the time of the clearance studies the mean plasma
I. By the twelfth week on the diets, tail pressures were slightly creatinines of the rats in Group II, regardless of diet, were not
higher in the fish oil—fed rats than in their dietary controls (fish significantly different. Proteinuria at the beginning of the diets
oil—fed rats, 125 12 mm Hg; control diet rats, 102 14 mm was the same. Twelve weeks after the initiation of the diets, the
Hg). rats fed fish oil had significantly more proteinuria than their
Rena/function. At the time rats were paired for initiation of dietary controls (81 22 mg/24 hr vs. 38 10 mg124 hr).
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this to a less extensive renal ablation and hence less severe
renal functional impairment than Group I. Blood pressures inGroup II, although slightly elevated, were lower than in GroupI, By the twelfth week on the diets, tail pressures were slightlyhigher in the fish oil—fed rats than in their dietary controls (fishoil—fe  rats, 12512 mm Hg; control diet rats, 10214 mmexperimental diets, mean plasma creatinine (± sEM) was 1.1.1 mg% (Table 3). This value is less than that of the Group Irats. At the tim  of the clearance studies the mean plasmacreatinines of the rats in Group II, regardless of diet, were notsignificantly different. Prot inuria at the beginning of the dietswas the s me. Twelve weeks af er the initiation of the diets, theH ).rats fed fish oil had significantly more proteinuria than theirRena! .fisnction. At the time rats were paired for initiation of dietary controls (812mg/24 hr vs. 310mg124 hr).Fig. 3. Histopathology of remnant renal segments from fish oil—fed rats vs. dietary controls (Group Ii). Masson Trichrome Stain. A and B: Renaltissue from normal age—matched unperfused kidney (A x100, B x250). All glomeruli appear normal and the interstitium is devuid of infiltratingcells. C and D are from 1-1/3 nephrectomized rats fed normal diets. C shows interstitial fibrosis with tubular dilatation and atrophy (C, ><100).D(x250) shows two glomeruli, one with glomerular adhesions and focal sclerosis. E and F are from 1-1/3 nephrectomized rats fed fish oil—enricheddiets. The interstitial disease is slightly more severe (E, x 100), however, the major changes occur in the glomeruli, more of which arc totallyscleros d (F, x2513).
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Normal
rat
Control diet
1-1/3 NX
N=5
Fish oil diet
1-1/3 NX
N=6
Glomerulus
Diameter urn 103 1 138 2 137 2
Percentage of to- 0 1.8% 1.1% 9.9% 2.0%'
tally scierosed
glomeruli
Tubules
Dilatation (0—4) 0 2.2 0.5 2.5 0.2
Atrophy (0—4) 0 1.4 0.5 1.6 0.4
Interstitial inflamma- 0 2.4 0.6 2.6 0.5
tion in cortex, me-
dulla (0—4) (Lym-
phocytes,
Macrophages)
Fibrosis (0—4) 0 1.8 0.3 2.0 0.5
Vessel thickening 0 1.0 0 1.3 0.2
(0—4)
Nephrocalcinosis (0—4) 0 2.4 0.5 2.0 0.5
and Tubular De-
struction
A similar analysis of a kidney from an age—matched, normal rat on the
control diet is included. Approximately 50 to 60 glomeruli per rat were
examined. 0 = absent; 1 = questionable; 2 = mild; 3 = moderate; 4 =
severe. Numbers represent mean SEM for each group. N = numberof
kidneys examined.
a P < 0.05 fish oil—enriched vs. contrQl diet kidney
One control rat died an anesthetic related death just prior to
the clearance study. Statistics were performed on the remaining
eleven rats using Student's unpaired t-test, shown in Table 3.
(13!!) hippuran plasma flow was slightly higher in the rats fed
fish oil (3.87 0.50 cc/mm vs. 2.91 0.55 cc/mm). However,
(TC99m) DTPA clearance of the fish oil—fed rats was significantly
lower than control (0.72 + 0.12 cc/mm vs. 1.09 + 0.15 cc/mm).
These values also held true when expressed as "cc/min/g
kidney" or "cc/mm/bOg rat weight." Filtration fraction, cal-
culated as (TC99m) DTPA clearance/('311) hippuran plasma flow,
was therefore markedly decreased in the fish oil—fed rats (0.19
0.02) versus the dietary controls (0.37 0.08).
Renal pathology. Shown in Figure 3 are representative
micrographs of renal remnants of a rat on the control (3C and D)
and fish oil diet (3E and F). Micrographs of a kidney from a
normal non-nephrectomized, age—matched control examined at
the same time are also shown (3A and B).
Results of the quantitative, blind analysis of all renal tissue
are shown in Table 4. The glomerular diameters of all rats in
Group II, independent of dietary manipulation, were greater
than diameters from normal rats, but there were no differences
between the rats on the two diets (fish oil, 137 2 m; dietary
control, 138 2 pm, normal non-nephrectomized, 103 /.LM). Of
the 50 to 60 glomeruli per rat examined almost all glomeruli
regardless of diet had some degree of distortion or focal
sclerosis; however, global sclerosis was much more prominent
in the fish oil—fed rats than in dietary controls (9.9% 2,0% vs.
1.8% 1.1%). Chronic inflammation, interstitial fibrosis, and
vascular thickening were slightly increased in the fish oil—fed
rats. The degree of tubular dilatation, atrophy and nephrocal-
cinosis was not significantly different.
Plasma lipids. It has been suggested that hyperlipidemia may
71±1% 72±3°/a
VEU III
Fig. 4. Plasrna lipids. Bar graphs show mean SEM for cholesterol("C," clear bar) and triglycerides ("T," solid bar). Normal rats on
standard chow diets (bars on left) are shown for comparison. Numbers
in clear bar represent percentage of cholesterol esters (CE). * = Jl
0.05, compared to normal rats; P < 0.05, compared to nephrectomized
rats on normal diets.
contribute to the progression of glomerular sclerosis [27—29].
The 1-1/3 NX rats on control diets had significant increases (P
< 0.05) in both plasma cholesterol (120 26 mg% vs. 67 3
mg%) and triglyceride (75 20 mg% vs. 40 6 mg%) compared
to non-nephrectomized rats analyzed at the same time (Fig. 4).
In contrast, both cholesterol and triglyceride levels remained
normal in 1-1/3 NX rats fed the fish oil—enriched diet. Fish
oil—induced reduction in triglycerides has been reported in
humans with hyperlipidemia [30].
Renal eicosanoid production. Table 5 depicts basal and
ionophore—stimulated radioimmunoassayable PGE2 and TBX2
production by isolated glomeruli and slices from cortices,
medullae and papillae of the remnant kidneys. Production of
these eicosanoids by segments from normal, age—matched
non-nephrectomized rats in our laboratory is shown in the left
column.
PGE2 production by glomeruli, cortices, and medullae, but
not papillac, of the partially nephrectomized rats on control
diets significantly exceeded that of normal rats. Enhanced
PGE2 synthesis by remnant glomeruli has been reported by
others [31, 32]. The lack of enhanced papillary PGE2 production
may relate to the lower interstitial osmolality in the diseased
kidney and, therefore, less stimulation of PGE2 synthesis [331.
Incubation in 2 /LM A23 187 resulted in two— to fourfold stimu-
lation of PGE2 by the kidneys of normal rats, but did not
stimulate the renal remnants from partially nephrectomized rats
on the control diet. This lack of ionophore stimulation suggests
that there is maximal stimulation of PGE2 synthesis even under
basal conditions in the remnant kidney.
The fish oil diet significantly reduced basal PGE2 production
by all segments of the remnant kidneys compared to cone-
sponding renal segments from the partially nephrectomized rats
on the control diet (Table 5). Papillary PGE2 production by rats
fed the fish oil—enriched diet was also significantly less than
normal rats. Similar to renal segments from the partially ne-
Table 4. Light microscopic analysis of remnant kidneys from 1-1/3
NX rats fed fish oil-enriched vs. control diets (Group 11)
E
'O
0.
E
ID
U)
140
120
100
80
60
40
20
C
Normal rats
normal diet
(N=3)
11/3 NX rats
normal diet
(N=5)
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Table 5.
Normal Rat 1-1/3 NX Rat 1-1/3 NX Rat
Control Control Diet Fish Oil Diet(n=4) (n=5) (n=6)
PGE2 ng/rng/protein/JO tn/n
Glomeruli
Basal
+A231872uM
Cortex
5.2±0.7 1
10.0±0.5 j <0.01 26±8"30±8 6±2"10±3"
Basal
+A2318720M
1.6±0.3
8.3±2.2 1<0.0
28±8a
3ti± 10
8±3"
7±1"
Medulla
Basal
+A231872uM
13±4
34±8 <0.0
115±31"
12!
36±8"
38±7"
Papilla
Basal
+A23 1872 uM
2,270 811
8,199 2,013 <0.05
780 214
705 253
284
266 120b,a
TXB2 np/mg protein/JO mm
Glomeruli
+A23i87
Cortex
1.9 0.3 ]
< 0.05 ] <0.05 ] < 0.05
Basal
+A23187
Undetectable
0.3 0.1 <Ow
1.1 0.3
1.3 0.4"
0.4
1.0 05b
Medulla
Basal
+A23187
Papilla
0.1 0.1 1
0.5 0.3 j <0.01
4 U
4 1"
0.7 03b
1.2 05h,a
Basal 4±1 8±2 2±l'"
+A23187 10±4 9±2 31ba
"P < 0.05 1-1/3 NX rat, control diet vs. normal rat, control dietb P < 0.05 1-1/3 NX rat, fish oil diet vs. normal rat, control diet
P < 0.05 1-1/3 NX rat, fish oil diet vs. 1-1/3 NX rat, control diet
Eicosanoid prodoction by segments of renal remnants from 1-1/3 NX rats (Group 11) on control vs. fish oil—enriched diets. Renal segments from
normal kidneys of age—matched rats on control diets are depicted in the left column.
phrectomized rats on the control diet, however, the remnant
renal segments from the fish oil—fed rats did not respond to
ionophore.
In contrast to the enhanced glornerular PGE2 production by
partially nephrectomized rats on the control diet 17 weeks after
surgery, glomerular TXB2 production at this time was not
different from normal. The ionophore caused a doubling of
TXB2 production by both preparations (Table 5). Cortical and
medullary TXB2 synthesis by the remnant kidney of rats fed the
control diets remained enhanced and failed to respond to the
ionophore. This enhanced cortical and medullary thromboxane
production by the remnant kidney may reflect the presence of
activated macrophages in the interstitium of this model (Table
4).
The fish oil—enriched diet significantly reduced basal TXB2
production by remnant glomeruli, cortices and medullae com-
pared to corresponding renal segments from partially ncphrec-
tomized rats on control diets. However, cortical and medullary
TXB2 production by fish oil—fed nephrectomized rats was still
greater than that by a normal non-nephrectomized rat and failed
to respond to the ionophore.
In summary, we found the following in the 1-1/3 nephrecto-
mized rat: Twelve weeks after the initiation of experimental
diets, rats fed the fish oil—enriched diet had significantly worse
functional and histologic renal deterioration than their dietary
controls. This happened in spite of a reduction in cholesterol,
triglycerides, and glomerular thromboxane production. Cortical
and medullary TXB2 production was less than that of the
dietary controls, but still enhanced compared to a normal rat.
PGE2 production by remnant glomeruli, cortices and medullae
from rats on the control diets was significantly elevated com-
pared to non-nephrectomized controls even seventeen weeks
after surgery. The fish oil diet significantly reduced PGE2 in
these tissues to levels no different frOm a normal rat.
Discussion
Renal ablation in the rat results in glomerular sclerosis and
death [27, 34j. The factors responsible for progressive renal
failure in this model are incompletely understood [35], but it has
been suggested that hypertension, both systemic and intraglo-
merular [36], intraglomerular rnicrothrombus formation [37],
with thromboxane release [31], and hyperlipidemia [27—291 may
all contribute to glomerular destruction. Of note, the method we
used to achieve renal ablation, that of ligation or excision of
part of the kidney [38—401 is not associated with the degree of
hypertension seen when the renal vessels are ligated [361. Fish
oil may exert an antiplatelet effect [5, 13—151, reduce serum
lipids [301, suppress the production of biologically active throm-
boxane [5, 41, 42, 44], and, perhaps, lower blood pressure [421.
We reasoned, therefore, that diptary enrichment with fish oil
would be beneficial in this model. We found the opposite. In
two separate experiments a fish oil-enriched diet was detrimen-
tal.
706Scharschrnidt ci olTable5.Normal Rat1-1/3 NXRat1-1/3 NX RatControlCon rol DietFish Oil Diet(n=4)( =5)(n=6)PGE2 ng/rng/protein/JO tn/nlomeruliBasa+A231872uMC rtex5.2±0.710.0±0.5j< . 126±8"30 86±2"10±3"l+A2318720.6± .38 3 2.28±8a3ti  108±3"7 1"Medullaasal+A231872uM1 44 8<0.0115±31"!36±8"3 ±7"PapillB l+A23 1872 uM,278 18 1992,013.05782 4528466120b,aTXB2 np/mg protein/JO mmGlo er li+ 23i87C rtex1.0 3]< 0.05] < .05] < 0.05asalA23187Undetectable.1Ow1.130 4"0.41.0 05bMe ullaB l+ 23187Papill0.53j<0.014U"0.703b1.205h,aasal4±8±22±l'"+A2318710 49 31ba"P <0.1-1/3 NX rat, control diet vs. normal rat, control dietb<51-1/3 NX rat, fish oil diet vs. normal rat, control diet1-1/3 NX rat, fish oil diet vs. 1-1/3 NX rat, control diet
Eicosanoid prodoction by segments of renal remnants from 1-1/3 NX rats (Group 11) on control vs. fish oil—enriched diets. Renal segments from
normal kidneys of age—matched rats on control diets are depicted in the left column.
phrectomized rats on the control diet, however, the remnantrenal segments from the fish oil—fed rats did not respond toio phor .In contrast to the enhanced glornerular PGE2 production bypartially nephrectomized rats on the control diet 17 weeks after
surgery, glomerular TXB2 production at this time was notdifferent from normal. The ionophore caused a doubling ofTXB2 production by both preparations (Table 5). Cortical and
medullary TXB2 synthesis by the remnant kidney of rats fed thecontrol diets remained enhanced and failed to respond to theionophore. This enhanced cortical and medullary thromboxaneproduction by the remnant kidney may reflect the presence of
activated macrophages in the interstitium of this model (Table4).Tfish oil—enriched diet significantly reduced basal TXB2production by remnant glomeruli, cortices and medullae com-pared to corresponding renal segments from partially ncphrec-tomized rats on control diets. However, cortical and medullaryTXB2 production by fish oil—fed nephrectomized rats was stillgreater than that by a normal non-nephrectomized rat and failedto respond to the ionophore.In summary, we found the following in the 1-1/3 nephrecto-
mized rat: Twelve weeks after the initiation of experimentaldiets, rats fed the fish oil—enriched diet had significantly worsefunctional and histologic renal deterioration than their dietarycontrols. This happened in spite of a reduction in cholesterol,triglycerides, and glomerular thromboxane production. Cortical
and medullary TXB2 production was less than that of the
dietary controls, but still enhanced c mpar d to a normal rat.
PGE2 production by remnant glomeruli, cortices and medullae
from rats on the control diets was significantly elevated com-
pared to non-nephrect mized controls even s venteen we ks
after surgery. The fish oil diet significantly reduced PGE2 in
these tissues to levels no different frOm a normal rat.Discus i n
Rena  ablation in the rat results in glomerular sclerosis and
eath [27, 34j. The factors responsible fo  progressiv  renal
failure in this model are incompletely understood [35], but it has
been suggested that hypertension, both systemic and intraglo-
merular [36], intraglomerular rnicrothrombus formation [37],
with thromb xane rel a e [31], and hyp rlipidemi  [27—291 may
all contribute to glomerular destruction. Of note, the method we
used to achieve renal ablat on, that of ligation or excision of
part of the kidney [38—401 is not associated with the degree of
hyperte sion seen when the renal vessels are ligated [361. Fish
oil may exert an antiplatelet effect [5, 13—151, reduce serum
lipids [301, suppress the production of biologically active thr m-
boxane [5, 41, 42, 44], and, perhaps, lower blood pressure [421.
We reasoned, therefore, that diptary enrichment with fish oil
would be beneficial in this model. We found the opposite. In
two separate experiments a fish oil-e riched diet was det imen-.
Dietary fish oil in rat subtotal nephrectomy 707
The effects of "omega-3" fatty acids, which are abundant in
fish oil, have been attributed in part to alterations in eicosanoid
metabolism. There is uniform agreement that they cause a
reduction in the amount of diene cyclooxygenase products
[41—461. Conversion of omega-3 fatty acids to triene cyclooxy-
genase products has also been stUdied [5, 7—9, 45] and they are
not converted as readily as arachidonate [5, 8, 451. It has even
been questioned whether the amount of triene cyclooxygenase
metabolites formed is enough to be of physiologic significance
[81. It has been more recently reported that EPA can also be
converted by the lipoxygenase pathway to LTB5, which has
markedly less chemotactic ability than LTB4 [10, 111.
Prickett, Robinson and Steinberg [161 and Kelley et al [171
found that the NZB/NZW, F1 and MRL-lpr mouse, fed from
birth the same fish oil—enriched diet as ours, survived longer
than their dietary controls and did not develop proteinuria. In a
prospective study, Hamazaki, Tateno and Shishido reported
that "EPA" capsules, administered to men with IgA nephrop-
athy and moderate renal insufficiency, stabilized serum creati-
nines compared to dietary controls [181. In contrast, we find the
opposite to be true in surgical renal ablation in rats.
Why would a fish oil diet be beneficial in some diseases, yet
detrimental in another? It may, in part, be due to its effects on
eicosanoid synthesis. Both systemic lupus erythematosus and
IgA nephropathy are immune—mediated and inflammatory in
origin. Surgical renal ablation is not. The factors initiating
glomerular damage in these diseases are different. Immune—
mediated diseases are associated with activation of the lipoxy-
genase pathway within the glomerulus [2, 31. There is no good
evidence of lipoxygenase activation in non-immune disease.
Fish oil may be beneficial in immune—mediated disease because
of simultaneous effects on the lipoxygenase pathways (to pro-
duce a biologically attenuated LTB5), and cyclooxygenase
pathways (to inhibit TXA2 synthesis). The progression of
immune- and nonimmune—mediated renal disease to glomerulo-
sclerosis may share common factors [471, but if the immune—
mediated renal disease remains active, the elements which
initiated the renal damage, including the lipoxygenase pathway,
continue to be present.
Both immune—mediated and nonimmune—mediated renal dis-
ease, including renal ablation, activate the cyclooxygenase
pathway within the glomerulus and stimulate glomerular or
renal TXB2 synthesis [1, 2, 31, 32, 48]. The source of throm-
boxane synthesis may be the glomerulus itself, but other
potential sources are activated platelets and/or inflammatory
cells. Chronic administration of a thromboxane synthase inhib-
itor by Purkerson et al for five weeks following subtotal renal
ablation resulted in functional and histologic improvement [311.
In contrast to the beneficial effects found by Purkerson, a
similar study by Stahl, et at, using the same model, had no
beneficial effect [32]. Others, however, have found thrombox-
ane suppression to be beneficial in both immune—mediated [2, 3,
48], and nonimmune—mediated renal disease [49, 50].
Fish oil diet did reduce the amount of TXB2 assayed in every
segment of the renal remnant, but fish oil supplementation and
pharmacologic thromboxane synthase inhibition cannot be re-
garded as equivalent therapies. Our diet not only reduced
thromboxane, it also markedly inhibited the production of
PGE2 by each segment of the renal remnant. These findings are
in agreement with others who find that EPA inhibits production
of AA-derived cyclooxygenase metabolites [41—46]. Adequate
production of prostaglandins, specifically PGE2 and PGI2, helps
to maintain glomerular filtration in clinical conditions associ-
ated with renal compromise, and thus are thought to be bene-
ficial [1, 21. Our present study supports this belief. This suggests
that a major effect of fish oil supplementation, suppression of
renal PGE2 production, is an untoward side effect and out-
weighs any beneficial effect derived from thromboxane inhibi-
tion.
We purposely did not initiate the fish oil diets until five weeks
after surgery in order to simulate a true clinical situation in
which therapy is not initiated until disease is present. Whether
pretreatment or perioperative initiation of the fish oil diet would
be beneficial or detrimental cannot be deduced from the results
of this study. We did not want to study the feasibility of fish oil
as a preventive therapy, but rather as an active intervention.
Fish oil supplementation is not the only fatty acid manipula-
tion which has been tried in different renal diseases with
conflicting results. Hurd et al reported that a diet enriched with
linoleic acid, the major arachidonate precursor, had no effect on
the clinical course of renal disease in the NZB/NZW, F1 mouse
[51]. Barcelli, Weiss and Pollak [40] and Heifetz, Purkerson and
Klahr [52] found that this same diet preserved renal function in
the partially nephrectomized rat. In Barcelli's study, the high
linoleate diet resulted in elevated PGE2, but not TXB2, produc-
tion by remnant cortices, and elevated TXB2, but not PGE2
production by remnant medullae. Regarding dietary fatty acid
manipulation in renal disease, it is interesting to note that,
lupus, the renal disease which responds favorably to fish oil,
does not respond to linoleate supplementation [51], and that the
progressive insufficiency induced by renal ablation, which is
attenuated by linoleate supplementation [40, 52], is actually
accelerated by fish oil supplementation.
Dietary fatty acid manipulation is potentially both a feasible
and powerful therapeutic maneuver [53]. To assume that all the
effects of dietary fatty acid manipulation are eicosanoid—medi-
ated, however, is simplistic. For example, the mechanisms by
which fish oil reduces serum lipids [30], alters the endocytic
response of macrophages [54], suppresses tumor growth [46],
and alters mitochondrial membrane electron—transport [55], are
not understood. One must remember that dietary polyunsatu-
rated fatty—acids are directly incorporated into cell membranes
and may affect any cellular event mediated or regulated by cell
membrane phospholipids. Ours is the first study which reports
that one type of fatty acid manipulation, that with fish oil, may
be detrimental in a specific disease model, subtotal renal
ablation in the rat. It emphasizes the importance of performing
studies which elucidate the exact mechanism(s) by which
dietary fatty—acid manipulation exerts its effects. In conclusion,
dietary fatty—acid manipulation should not be recommended as
a global therapy but, instead, may have to be tailored for
specific diseases.
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Appendix. Abbreviations
Arachidonic acid
Diethylenetriamine pentaacetic acid
Eicosapentaenoic acid
Glomerular filtration rate
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